Brief: Integral Diagnostics Says Australia Q1 Revenue Growth Of 8.4% vs PCP

Integral Diagnostics

03/11/2023 01:19

Nov 3 (Reuters) - Integral Diagnostics Ltd  IDX.AX :
    * IN AUSTRALIA Q1 REVENUE GROWTH OF 8.4% VERSUS PRIOR
CORRESPONDING PERIOD
    * SEES  FY24 REPLACEMENT AND GROWTH CAPEX TO BE IN RANGE OF
A$30M
TO A$40M
    * IN NEW ZEALAND Q1 4.1% NZD INCREASE IN REVENUE COMPARED
WITH
PRIOR CORRESPONDING PERIOD

Source text for Eikon:  ID:nASX7ScyhX 
Further company coverage:  IDX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))